Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
venture capital (VC)
Marketing
GenEdit rebrands as BreezeBio, raises $60M for genetic drug R&D
The biotech has raised $60 million to take a drug candidate designed to restore immune tolerance in Type 1 diabetes into IND-enabling studies.
Nick Paul Taylor
Feb 25, 2026 7:00am
Orca rides $250M funding wave toward cancer cell therapy launch
Jan 9, 2026 11:19am
Avalyn adds $100M to advance inhaled versions of IPF pills
Jul 22, 2025 10:44am
'The Top Line': Which biotechs scored big VC dollars in 2022?
Apr 14, 2023 6:00am
Evonik backs Allay's development of pain therapy implants
Dec 13, 2022 10:43am
Re-Vana reels in $12M to develop sustained-release eye implants
Dec 6, 2022 10:26am
